Multiple sclerosis. Lancet, pp.1502-1519, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00996686
Natural history of multiple sclerosis: a unifying concept, Brain, vol.129, issue.3, pp.606-622, 2006. ,
DOI : 10.1093/brain/114.6.2437
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study, The Lancet Neurology, vol.8, issue.3, pp.254-60, 2009. ,
DOI : 10.1016/S1474-4422(09)70021-3
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis, New England Journal of Medicine, vol.362, issue.5, pp.387-401 ,
DOI : 10.1056/NEJMoa0909494
URL : https://hal.archives-ouvertes.fr/hal-00617764
Defining the clinical course of multiple sclerosis: The 2013 revisions, Neurology, vol.84, issue.9, p.963, 2015. ,
DOI : 10.1212/01.wnl.0000462309.76486.c5
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort, JAMA Neurology, vol.72, issue.2, pp.152-160, 2015. ,
DOI : 10.1001/jamaneurol.2014.3537
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS), Neurology, vol.33, issue.11, pp.1444-52, 1983. ,
DOI : 10.1212/WNL.33.11.1444
Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning, Neurology, vol.41, issue.5, pp.692-698, 1991. ,
DOI : 10.1212/WNL.41.5.692
Diagnostic criteria for multiple sclerosis: 2005 revisions to the ???McDonald Criteria???, Annals of Neurology, vol.6, issue.6, pp.840-846, 2005. ,
DOI : 10.1212/WNL.53.6.1184
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011. ,
DOI : 10.1002/ana.21464
Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis, Brain Research Reviews, vol.36, issue.2-3, pp.249-57, 2001. ,
DOI : 10.1016/S0165-0173(01)00101-1
MMPs in the central nervous system: Where the good guys go bad, Seminars in Cell & Developmental Biology, vol.19, issue.1, pp.42-51, 2008. ,
DOI : 10.1016/j.semcdb.2007.06.003
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis, Multiple Sclerosis Journal, vol.2010, issue.9, 2015. ,
DOI : 10.1093/brain/124.9.1743
Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients, Journal of Neuroimmunology, vol.249, issue.1-2, pp.56-65, 2012. ,
DOI : 10.1016/j.jneuroim.2012.04.001
Metalloproteinases and their tissue inhibitors in multiple sclerosis, J Autoimmun, 1999. ,
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis, Brain, vol.122, issue.2, pp.191-198, 1999. ,
DOI : 10.1212/WNL.46.6.1626
Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis, Clinical Immunology, vol.130, issue.2, pp.145-50, 2009. ,
DOI : 10.1016/j.clim.2008.09.010
Bio-markers of disease activity and response to therapy in multiple sclerosis, Clinical Neurology and Neurosurgery, vol.106, issue.3, pp.249-54, 2004. ,
DOI : 10.1016/j.clineuro.2004.02.008
Matrix metalloproteinases biomarkers in multiple sclerosis, The Lancet, vol.365, issue.9467, pp.1291-1294, 2005. ,
DOI : 10.1016/S0140-6736(05)61008-2
Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis, Disease Markers, vol.22, issue.4, pp.235-279, 2006. ,
DOI : 10.1155/2006/709869
Frequency of cognitive impairment dramatically increases during the first 5 years of multiple sclerosis, Journal of Neurology, Neurosurgery & Psychiatry, vol.82, issue.10, pp.1157-1166, 2011. ,
DOI : 10.1136/jnnp.2010.213744
Test Review: Wechsler, D. Manual for the Wechsler Adult Intelligence Scale, Revised, J Psychoeduc Assess, 1981. ,
Screening for dementia by memory testing, Neurology, vol.38, issue.6, pp.900-903, 1988. ,
DOI : 10.1212/WNL.38.6.900
Paced auditory serial addition test: Adult norms and moderator variables, Journal of Clinical and Experimental Neuropsychology, vol.6, issue.4, pp.473-83, 1997. ,
DOI : 10.1080/13854048708520046
Cognitive impairment in multiple sclerosis, The Lancet Neurology, vol.7, issue.12, pp.1139-51, 2008. ,
DOI : 10.1016/S1474-4422(08)70259-X
Fatigue in Multiple Sclerosis, Archives of Neurology, vol.45, issue.4, pp.435-442, 1988. ,
DOI : 10.1001/archneur.1988.00520280085020
Fatigue and declines in cognitive functioning in multiple sclerosis, Neurology, vol.55, issue.7, pp.934-943, 2000. ,
DOI : 10.1212/WNL.55.7.934
Psychosocial correlates of fatigue in multiple sclerosis, Archives of Physical Medicine and Rehabilitation, vol.77, issue.2, pp.165-70, 1996. ,
DOI : 10.1016/S0003-9993(96)90162-8
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis, The Lancet, vol.353, issue.9157, pp.964-973, 1999. ,
DOI : 10.1016/S0140-6736(98)03053-0
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis, New England Journal of Medicine, vol.346, issue.3, pp.158-64, 2002. ,
DOI : 10.1056/NEJMoa011341
DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications, Multiple Sclerosis International, vol.22, issue.8, p.671730, 2013. ,
DOI : 10.1212/WNL.0b013e318206ca61
Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia, NeuroImage, vol.20, issue.3, pp.1714-1736, 2003. ,
DOI : 10.1016/j.neuroimage.2003.07.005
diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis, NMR in Biomedicine, vol.51, issue.1, pp.589-97, 2008. ,
DOI : 10.1212/WNL.51.1.234
Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging, Neurobiology of Disease, vol.28, issue.1, pp.30-38, 2007. ,
DOI : 10.1016/j.nbd.2007.06.011
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data, NeuroImage, vol.31, issue.4, pp.1487-505, 2006. ,
DOI : 10.1016/j.neuroimage.2006.02.024
Diffusion abnormality maps in demyelinating disease: Correlations with clinical scores, European Journal of Radiology, vol.81, issue.3, pp.386-91 ,
DOI : 10.1016/j.ejrad.2011.12.014
Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis, Journal of Magnetic Resonance Imaging, vol.130, issue.2, 2010. ,
DOI : 10.1212/WNL.56.7.926
Multiple sclerosis normal-appearing white matter: Pathology-imaging correlations, Annals of Neurology, vol.60, issue.pt 2, pp.764-73, 2011. ,
DOI : 10.1212/01.WNL.0000055926.69643.03
Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient Disability in Multiple Sclerosis, Journal of Neuroimaging, vol.15, issue.2, 2014. ,
DOI : 10.1002/nbm.782
Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study, Journal of Neurology, Neurosurgery & Psychiatry, vol.33, issue.10, pp.1109-1124, 2014. ,
DOI : 10.1002/hbm.21279
Subcortical atrophy and cognition: Sex effects in multiple sclerosis, Neurology, vol.79, issue.17, pp.1754-61, 2012. ,
DOI : 10.1212/WNL.0b013e3182703f46
Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis, Annals of Neurology, vol.70, issue.1, pp.43-52, 2014. ,
DOI : 10.1136/jnnp.70.4.494
Association of Neocortical Volume Changes With Cognitive Deterioration in Relapsing-Remitting Multiple Sclerosis, Archives of Neurology, vol.64, issue.8, pp.1157-61, 2007. ,
DOI : 10.1001/archneur.64.8.1157
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria, Annals of Neurology, vol.64, issue.suppl 2, pp.292-302, 2011. ,
DOI : 10.1002/ana.21464
Natural history of multiple sclerosis: a unifying concept, Brain, vol.129, issue.3, pp.606-622, 2006. ,
DOI : 10.1093/brain/114.6.2437
Defining the clinical course of multiple sclerosis: The 2013 revisions, Neurology, vol.84, issue.9, p.963, 2015. ,
DOI : 10.1212/01.wnl.0000462309.76486.c5
Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort, JAMA Neurology, vol.72, issue.2, pp.152-160, 2015. ,
DOI : 10.1001/jamaneurol.2014.3537
Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process, Brain, vol.126, issue.4, 2003. ,
DOI : 10.1093/brain/awg081
URL : https://hal.archives-ouvertes.fr/hal-00427394
The clinico-radiological paradox in multiple sclerosis revisited, Current Opinion in Neurology, vol.15, issue.3, pp.239-284, 2002. ,
DOI : 10.1097/00019052-200206000-00003
Correlations between changes in disability and T2-weighted brain MRI activity in multiple sclerosis: A follow-up study, Neurology, vol.45, issue.2, pp.255-60, 1995. ,
DOI : 10.1212/WNL.45.2.255
Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis, The Lancet, vol.353, issue.9157, pp.964-973, 1999. ,
DOI : 10.1016/S0140-6736(98)03053-0
A Longitudinal Study of Abnormalities on MRI and Disability from Multiple Sclerosis, New England Journal of Medicine, vol.346, issue.3, pp.158-64, 2002. ,
DOI : 10.1056/NEJMoa011341
Cognitive impairment in multiple sclerosis, The Lancet Neurology, vol.7, issue.12, pp.1139-51, 2008. ,
DOI : 10.1016/S1474-4422(08)70259-X
MMPs in the central nervous system: Where the good guys go bad, Seminars in Cell & Developmental Biology, vol.19, issue.1, pp.42-51, 2008. ,
DOI : 10.1016/j.semcdb.2007.06.003
Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis, Clinical Immunology, vol.130, issue.2, pp.145-50, 2009. ,
DOI : 10.1016/j.clim.2008.09.010
Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients, Journal of Neuroimmunology, vol.249, issue.1-2, pp.56-65, 2012. ,
DOI : 10.1016/j.jneuroim.2012.04.001
Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis, Brain, vol.122, issue.2, pp.191-198, 1999. ,
DOI : 10.1212/WNL.46.6.1626
Metalloproteinases and their tissue inhibitors in multiple sclerosis, J Autoimmun, 1999. ,
Matrix metalloproteinases biomarkers in multiple sclerosis, The Lancet, vol.365, issue.9467, pp.1291-1294, 2005. ,
DOI : 10.1016/S0140-6736(05)61008-2
Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data, NeuroImage, vol.31, issue.4, pp.1487-505, 2006. ,
DOI : 10.1016/j.neuroimage.2006.02.024
Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference, NeuroImage, vol.44, issue.1, 2009. ,
DOI : 10.1016/j.neuroimage.2008.03.061
Gray- and White-Matter Changes 1 Year after First Clinical Episode of Multiple Sclerosis: MR Imaging, Radiology, vol.257, issue.2, pp.448-54, 2010. ,
DOI : 10.1148/radiol.10100626
Combining tractography and cortical measures to test system-specific hypotheses in multiple sclerosis, Multiple Sclerosis Journal, vol.9, issue.5, 2010. ,
DOI : 10.1097/00001648-199001000-00010
Relationships of brain white matter microstructure with clinical and MR measures in relapsing-remitting multiple sclerosis, Journal of Magnetic Resonance Imaging, vol.130, issue.2, pp.309-325, 2010. ,
DOI : 10.1212/WNL.56.7.926
Diffuse and Focal Corticospinal Tract Disease and Its Impact on Patient Disability in Multiple Sclerosis, Journal of Neuroimaging, vol.15, issue.2, 2014. ,
DOI : 10.1002/nbm.782
Corpus callosal diffusivity predicts motor impairment in relapsing???remitting multiple sclerosis: A TBSS and tractography study, NeuroImage, vol.55, issue.3, pp.1169-77, 2011. ,
DOI : 10.1016/j.neuroimage.2010.10.077
Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis, Neurology, vol.78, issue.13, pp.969-75, 2012. ,
DOI : 10.1212/WNL.0b013e31824d5859
Progressive decline in fractional anisotropy on serial DTI examinations of the corpus callosum: a putative marker of disease activity and progression in SPMS, Neuroradiology, vol.188, issue.4, pp.287-97 ,
DOI : 10.2214/AJR.05.2212
Diffusion Tensor Imaging of Corpus Callosum Integrity in Multiple Sclerosis: Correlation with Disease Variables, Journal of Neuroimaging, vol.31, issue.1, pp.33-40 ,
DOI : 10.1002/jmri.22062
Quantitative pathological evidence for axonal loss in normal appearing white matter in multiple sclerosis, Annals of Neurology, vol.36, issue.3, pp.391-396, 2000. ,
DOI : 10.1148/radiology.196.2.7617869
Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia, NeuroImage, vol.20, issue.3, pp.1714-1736, 2003. ,
DOI : 10.1016/j.neuroimage.2003.07.005
Selective vulnerability of cerebral white matter in a murine model of multiple sclerosis detected using diffusion tensor imaging, Neurobiology of Disease, vol.28, issue.1, pp.30-38, 2007. ,
DOI : 10.1016/j.nbd.2007.06.011
diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis, NMR in Biomedicine, vol.51, issue.1, pp.589-97, 2008. ,
DOI : 10.1212/WNL.51.1.234
Neutralizing antibodies against IFN-?? in multiple sclerosis: antagonization of IFN-?? mediated suppression of MMPs, Brain, vol.127, issue.2, pp.259-68, 2004. ,
DOI : 10.1093/brain/awh028
Biomarkers Indicative of Blood-Brain Barrier Disruption in Multiple Sclerosis, Disease Markers, vol.22, issue.4, pp.235-279, 2006. ,
DOI : 10.1155/2006/709869
Interferon beta-1b inhibits gelatinase secretion and in vitro migration of human T cells: A possible mechanism for treatment efficacy in multiple sclerosis, Annals of Neurology, vol.1, issue.6, pp.846-52, 1996. ,
DOI : 10.1038/nm0395-211
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis, Multiple Sclerosis Journal, vol.2010, issue.9, 2015. ,
DOI : 10.1093/brain/124.9.1743
Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging, Journal of Neurology, vol.19, issue.3, pp.390-397, 2008. ,
DOI : 10.1212/WNL.54.7.1421
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study, The Lancet Neurology, vol.8, issue.3, pp.254-60, 2009. ,
DOI : 10.1016/S1474-4422(09)70021-3
A placebocontrolled trial of oral fingolimod in relapsing multiple sclerosis, N Engl J Med. 2010 Feb, vol.4362, issue.5, pp.387-401 ,
URL : https://hal.archives-ouvertes.fr/hal-00617764